中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effects of Cranberry Supplementation on Chronic Kidney Disease Patients.

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态主动,不招募
赞助商
Universidade Federal Fluminense

关键词

抽象

Patients with chronic kidney disease (CKD) have several complications that are linked to oxidative stress and inflammation, and among the most recently studied is the alteration of the intestinal microbiota. Considering this scenario, bioactive compounds have been considered as a therapeutic alternative in the modulation of intestinal microbiota as well as transcription factors such as nuclear-kappa factor B (NF-κB) and factor 2 nuclear factor-related erythroid 2 Nrf2), involved with oxidative stress and inflammation. Among several foods, cranberry is a fruit rich in flavonoids and other polyphenols, which has antioxidant, anti-inflammatory and immunoregulatory actions and may be an adjuvant treatment for CKD complications. However, clinical evidence evaluating the effects of cranberry is limited and there are no studies specifically involving patients with CKD. Thus, the present randomized crossover double-blind crossover with placebo-controlled washout period will aim to evaluate the effects of cranberry supplementation on the modulation of the intestinal microbiota and expression of transcription factors as well as cytokine levels inflammatory effects of CKD patients.

描述

This is a longitudinal study with a randomized crossover design, double-blind, placebo-controlled, and with washout period. Thirty non-dialysis patients of both genders, aged between 18 and 60 years and with CKD stage3-4 (glomerular filtration rate < 59 mL/min/1.73 m2) will be included in the study. Pregnant patients, smokers and those under use of antibiotics in the last 3 months, or in use antithrombotic, pre-, pro- or synbiotic supplements, antioxidant supplements or habitual cranberry intake will be excluded. In addition, those with autoimmune and infectious diseases, cancer, liver diseases and HIV will also not be included in the study. The patients that fulfill the eligible criteria and sign the ethical informed consent will be randomized to either Group A (Cranberry) or Group B (Placebo). During 12 weeks, patients allocated in group A will receive capsules containing cranberry extract (Vaccinium macrocarpon to 25% anthocyanosides 160mg, equivalent to 40mg anthocyanosides), once daily (lunch), totaling 500mg / day and those allocated in the group B will receive a placebo (500mg of corn starch). After the supplementation period, a 12-week washout will be performed for subsequent crossover of the supplement. The randomization will be computed in the ratio of 1: 1, with block size of 15 (Cranberry group and Control), to receive cranberry or placebo. This project was approved by the Ethics Committee of the Faculty of Medicine-UFF, n. 2.653.752.

日期

最后验证: 04/30/2020
首次提交: 09/27/2018
提交的预估入学人数: 05/02/2020
首次发布: 05/06/2020
上次提交的更新: 05/02/2020
最近更新发布: 05/06/2020
实际学习开始日期: 07/31/2018
预计主要完成日期: 11/30/2021
预计完成日期: 11/30/2021

状况或疾病

Renal Insufficiency, Chronic
Inflammation
Oxidative Stress
Gastrointestinal Microbiome

干预/治疗

Dietary Supplement: Cranberry

Dietary Supplement: Placebo

-

手臂组

干预/治疗
Active Comparator: Cranberry
Administration of 2 capsules with 500mg (Miralys Ltda) of cranberry extract per day, for 8 weeks
Dietary Supplement: Cranberry
The patients will receive 2 capsules per day containing 500mg of cranberry extract for 8 weeks
Placebo Comparator: Placebo
Administration of 2 capsules with 500mg of maize starch per day, for 8 weeks
Dietary Supplement: Placebo
The patients will receive 2 capsules per day containing 500mg of maize starch for 8 weeks

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Clinical diagnosis of Chronic Kidney Disease in conservative treatment

- Aged 18 years or older

- Must be able to swallow tablets

Exclusion Criteria:

- Patients pregnant

- Smokers

- Using antibiotics in the last 3 months

- Using antioxidant supplements in the last 3 months

- Usual intake of cranberry fruit or extract

- Clinical diagnosis of infectious diseases

- Clinical diagnosis of Cancer

- Clinical diagnosis of AIDS

结果

主要结果指标

1. Antioxidants and anti-inflammatory biomarkers [3 months]

Evaluate the supplementation effects in anti-inflammatory biomarkers- Nrf2 and antioxidants enzymes

2. Inflammatory biomarkers [3 months]

Evaluate the supplementation effects in inflammatory biomarkers- factor nuclear kappa B (NFkB), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha)

3. Biochemical Routine [12 weeks]

Urea, creatinine, albumin, lipid profile plasma levels

4. Uremic toxins [6 months]

P-cresol, indoxyl sulfate plasma levels

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge